In the present study, we used purified GM3 ganglioside to immunize β3Gn-T5 knockout mice to generate IgG monoclonal antibodies (IgG3 subclass) against human ovarian cancer tissues. This evidence concerns the gene IGHG3 and ovarian cancer.